Marked hepatomegaly due to AA type amyloidosis in a case with Castleman's disease

International Journal of Hematology

Volumn 84, Issue 1, 2006, Pages 70-73

  Yamagata, Noboru ^a,c   Fujio, Jyunko ^a   Hirai, Risen ^a   Matsumaru, Mutsumi ^a   Tanimura, Satoshi ^a   Inokuchi, Chiho ^a   Shikai, Tateki ^a   Takezako, Naoki ^a   Nasu, Michiyo ^a   Sakata, Yoichi ^b   Sata, Naohiro ^b   Nagai, Hideo ^b   Saito, Ken ^b   Miwa, Akiyoshi ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c Takanohara Central Hospital   (Japan)

Author keywords

Amyloid A protein; Castleman's disease; Hepatic amyloidosis

Indexed keywords

AMYLOID A PROTEIN; PYROPHOSPHATE TECHNETIUM TC 99M; SERUM AMYLOID A;

ABDOMINAL MASS; ADULT; AMYLOIDOSIS; ANEMIA; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FATIGUE; FEMALE; FEVER; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER AMYLOIDOSIS; LIVER BIOPSY; LIVER DISEASE; LIVER DYSFUNCTION; LIVER FUNCTION TEST; PATIENT REFERRAL; PHYSICAL EXAMINATION; RARE DISEASE; THROMBOCYTOPENIA; TREATMENT OUTCOME; LIVER; METABOLISM; MIDDLE AGED; PATHOLOGY; PLASMA CELL;

AMYLOIDOSIS; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HEPATOMEGALY; HUMANS; LIVER; MIDDLE AGED; PLASMA CELLS; SERUM AMYLOID A PROTEIN;

EID: 33748637367     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.05126     Document Type: Article

References (20)

1. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph-node hyperplasia resembling thymoma. Cancer. 1956;9:822-830.
2. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29:670-683.
3. McCarty MJ, Vukelja SJ, Banks PM, Weiss RB. Angiofollicular lymph node hyperplasia (Castleman's disease). Cancer Treat Rev. 1995;21:291-310.
4. Herrada J, Cabanillas FF. Multicentric Castleman's disease. Am J Clin Oncol. 1995;18:180-183.
5. Palestro G, Turrini F, Pagano M, Chiusa L. Castleman's disease. Adv Clin Path. 1999;3:11-22.
6. Pilon VA, Gomez LG, Butler JJ. Systemic amyloidosis associated with a benign mesenteric lymphoid mass. Am J Clin Pathol. 1982; 78:112-116.
7. Ordi J, Grau JM, Junque A, Nomdedeu B, Palacin A, Cardesa A. Secondary (AA) amyloidosis associated with Castleman's disease. Am J Clin Pathol. 1993;100:394-397.
8. Tanaka T, Horita M, Shibayama H, et al. Secondary amyloidosis associated with Castleman's disease. Intern Med. 1995;34:122-126.
9. Kazes I, Deray G, Jacobs C. Castleman's disease and renal amyloidosis. Ann Intern Med. 1995;122:395-396.
10. Lomena F, Rusello R, Pons F, et al. Abnormal scintigraphic evolution in AA hepatic amyloidosis. Clin Nucl Med. 1988;13:194-196.
11. Falk RH, Lee VW, Rubinow A, Hood WB, Cohen AS. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis. Am J Cardiol. 1983;51:826-830.
12. Altiparmak MR, Pamuk GE, Pamuk ON, Dogusoy G. Secondary amyloidosis in CD: review of the literature and report of a case. Ann Hematol. 2002;81:336-339.
13. Gillmore JD, Lovat LB, Persey MR, et al. Amyloid load and clonical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet. 2001;358:24-29.
14. Perfetti V, Bellotti V, Maggi A, et al. Reversal of nephrotic syndrome due to reactive amyloidosis (AA-type) after excision of localized Castleman's disease. Am J Hematol. 1994;46:189-193.
15. Lui SL, Chan KW, Li FK, Cheng TK, Chan TM. Castleman's disease and mesangial proliferative glomerulonephritis: the role of interleukin-6. Nephron. 1998;78:323-327.
16. Bowne WB, Lewis JJ, Filippa DA, et al. The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer. 1999;85:706-717.
17. Chronowski GM, Ha CS, Wilder RB, Cabanillas F, Manning J, Cox JD. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer. 2001;92:670-676.
18. Derici U, Arinsoy T, Ataoglu O, et al. Localized Castleman's disease and nephrotic syndrome not responsive to resection plus colchicine therapy. Ann Hematol. 2002;81:399-401.
19. Ikeda S, Chisuwa H, Kawasaki S, et al. Systemic reactive amyloidosis associated with Castleman's disease: serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum. J Clin Pathol. 1997;50:965-967.
20. Lachmann HJ, Gilbertson JA, Gillmore JD, et al. Unicentric Castleman's disease complicated by systemic AA amyloidosis: a curable disease. Q J Med. 2002;95:211-218.